Monday - December 23, 2024
Miller School Spinoff Uses RNA to Tackle Deadly Disease
December 14, 2024
MIAMI, Florida, Dec. 14 (TNSres) -- The University of Miami Miller School of Medicine issued the following news:

* * *

Article Summary

* WiNK Therapeutics was honored at the Florida Innovation Conference as the most promising, emerging company.

* Co-founder Dr. Paolo Serafini and team developed RNA aptamers to deliver therapeutics to beta cells in people with diabetes.

* Success will will be a two-part process: replacing the beta c . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products